All In MedTech

FDA Clearance Tracker · P910056-S027

enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 8, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 8, 2018

Approved

Time to decision

221 days

Received Oct 30, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P910056-S027
Device name
enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T)
Applicant location
Irvine, CA
Received
Oct 30, 2017
Decided
Jun 8, 2018
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P910056

Device type

Device class
Class III
Regulation
21 CFR 886.3600
Specialty
Ophthalmology

Every decision under product code MJP

FDA's approval statement

As written in FDA's record.

Approval for the enVista One-Piece Hydrophobic Acrylic Toric Intraocular Lens (Model MX60T). The device is indicated for primary implantation in the capsular bag of the eye in adult patients for visual correction of aphakia and corneal astigmatism following removal of a cataractous lens for improved uncorrected distance vision.

Source documents

Other decisions for Bausch & Lomb, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.